Strategy to Adapt Botulinum Toxin Doses in Dystonia

Central Hospital, Nancy, France100 enrolled

Overview

The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended. We we ll study the increase of the dose injected over the time, the side effects... The hypothesis is that we inject smaller doses than we could regarding the recommandations

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Dystonia

Interventions

Botulinum toxinDRUG

Botulinum toxin doses injected in dystonia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients over 18 years old followed for dystonia and treated with botulinum toxin Exclusion Criteria: * first dose of botulinum toxin not available

Outcomes

Primary Outcomes

First dose of botulinum toxin injected, U

dose injected in U

Time frame: 30 years

Secondary Outcomes

Effective dose of botulinum toxin

dose injected in U

Time frame: 30 years

Side effects

diplopia, ptosis and others

Time frame: 30 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.